Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Aphaia Pharma Headquarters: Switzerland Technology: oral glucose formulation Lead candidate: APH-012 As disruptions in the guts natural responses to food intake are linked to metabolic diseases, such as obesity, Swiss biotech company Aphaia Pharma has come up with a way to restore these said natural responses, different from conventional obesity therapies like GLP-1 agonists
Enzymology and Detoxification Pathways : Supports assays for glutathione-linked enzymes involved in antioxidant defense and xenobiotic conjugation
If you notice any changes, like feeling anxious or changes in appetite, write them down
"Lo que haces para perder peso es a corto plazo
US$ 28.74
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 20.72
US$ 29.05
